
Japan Tissue Engineering (7774) Earnings Report: Net Sales Surge 79.9% YoY, Operating Income Reaches 59 Million Yen
StockClub
公開日時: Jul 30, 2026, 02:31 AM
Sentiment Analysis
Japan Tissue Engineering (7774) has released its latest financial results, reporting net sales of 766 million yen, representing a significant year-on-year increase of +79.9%. In terms of profitability, the company posted an operating income of 59 million yen, ordinary income of 63 million yen, and net income of 52 million yen, with earnings per share (EPS) standing at 1.29 yen.
From a financial and valuation perspective, the company maintains a high equity ratio of 87.0%, reflecting a robust financial foundation, although retained earnings stand at -680 million yen. Profitability metrics show a Return on Equity (ROE) of 1.02% and a Return on Assets (ROA) of 0.88%, with EBITDA recorded at 60 million yen. Backed by substantial top-line growth, the company has returned to profitability, drawing attention to its future operational expansion and margin improvements.
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。